clavulanic acid has been researched along with E coli Infections in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (15.91) | 18.7374 |
| 1990's | 9 (20.45) | 18.2507 |
| 2000's | 8 (18.18) | 29.6817 |
| 2010's | 13 (29.55) | 24.3611 |
| 2020's | 7 (15.91) | 2.80 |
| Authors | Studies |
|---|---|
| Crast, LB; Gottstein, WJ; Graham, RG; Haynes, UJ; McGregor, DN | 1 |
| Aminu, RF; Mofolorunsho, KC; Ocheni, HO; Olowonibi, OO; Omatola, CA | 1 |
| Minami, K; Nishihara, M; Oda, K; Suzuki, K; Uchiyama, K; Ukimura, A; Yamada, T | 1 |
| Abu-Raideh, J; Al-Tamimi, M; Albalawi, H; Alhaj, F; Khasawneh, AI; Shalabi, M | 1 |
| Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T | 1 |
| Chen, J; Liu, W; Zhao, F | 1 |
| Acampora, A; Albano, R; Buonsenso, D; Ferrari, V; Fiori, B; Pata, D; Sanguinetti, M; Spanu, T; Valentini, P | 1 |
| Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I | 1 |
| Agunos, A; Caffrey, N; Checkley, S; Gow, S; Nekouei, O | 1 |
| Batard, E; Caillon, J; Chapelet, G; Javaudin, F; Marquet, A; Montassier, E; Vibet, MA | 1 |
| Alzate-Morales, JH; Fritz, RA; Mulholland, AJ; Spencer, J; van der Kamp, MW | 1 |
| Buter, RGJ; Gonggrijp, MA; Heuvelink, AE; Lam, TJGM; Ter Bogt-Kappert, CC; van Schaik, G; Velthuis, AGJ | 1 |
| Cohen Stuart, J; Leverstein-van Hall, MA; Muilwijk, J; Waar, K | 1 |
| Fang, ZL; Huang, X; Huang, YM; Qing, Y; Tian, GB; Zhang, XF | 1 |
| Bou, G; Cercenado, E; Fernández-Martínez, M; González-López, JJ; Martínez-Martínez, L; Miró, E; Navarro, F; Oliver, A; Ortega, A; Oteo, J; Pascual, A | 1 |
| Chlebicki, MP; Tan, CW | 1 |
| Kechrid, A; Mercuri, PS; Power, P; Réjiba, S | 1 |
| Englen, MD; Fedorka-Cray, PJ; Frye, JG; Lindsey, RL; Meinersmann, RJ; Thitaram, SN | 1 |
| Beceiro, A; Bou, G; Dhanji, H; Doumith, M; Downie, G; Doyle, M; Gaulton, T; Hickey, M; Livermore, DM; Maharjan, S; Soares, NC; Warner, M; Woodford, N | 1 |
| Galani, I; Giamarellou, H; Katsarolis, I; Lampri, N; Petrikkos, G; Poulakou, G; Souli, M | 1 |
| Bingen, E; Biscardi, S; Cohen, R; Epaud, R; Jaby, O; Madhi, F | 1 |
| Millán Rodríguez, F; Rousaud Barón, A; Rousaud Barón, F | 1 |
| Mayayo Dehesa, T; Navas Elorza, E; Quereda Rodríguez-Navarro, C; Rodríguez-Patrón Rodríguez, R | 1 |
| Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M | 1 |
| Palmer, C; Shemko, M; Shetty, N; Skippen, I | 1 |
| Bodonaik, N; Saunders, G | 1 |
| Akova, M; Hasçelik, G; Metan, G; Zarakolu, P | 1 |
| Brook, I; Coolbaugh, JC; Walker, RI | 1 |
| Howells, CH; Menday, AP; O'Dowd, TC; Ribeiro, CD; Smail, JE | 1 |
| Bingen, E; Rangaraj, M; Safran, C | 1 |
| Bordon, F; Gutmann, L; Kitzis, MD; Sirot, D; Zhou, XY | 1 |
| Alós, JI; Gómez-Garcés, JL; Mateos, MV | 1 |
| Phillips, I; Shannon, K; Wu, PJ | 1 |
| de Micco, P; Gouin, F; Mallet, NM; Martin, A; Martin, C; Ruperti, A; Sastre, B; Viviand, X | 1 |
| Kim, KH; Park, KW; Yim, CB | 1 |
| Chen, Y; Gao, L; Hou, F; Li, J | 1 |
| Chong, Y; Inoue, M; Lee, K; Lim, JK; Okamoto, R; Yong, D; Yum, J | 1 |
| Alonso, R; Cisterna, R; Colom, K; Fernández-Aranguiz, A | 1 |
| Cherubin, CE | 1 |
| Aubert, G; Dorche, G; Dumont, N; el Fassi, M; Peyle, V | 1 |
| Al-Sabbagh, A; McCracken, GH; Olsen, KD; Syrogiannopoulos, GA | 1 |
| Buergelt, CD; Franks, PP; Gaskin, JM; Keefe, TJ; Senior, DF | 1 |
| Dijkmans, BA; Mattie, H; Vaishnav, J | 1 |
| Aldridge, KE; Derks, FW; Marier, RL; Martin, DH; Sanders, CV | 1 |
3 trial(s) available for clavulanic acid and E coli Infections
| Article | Year |
|---|---|
A comparative trial of pivmecillinam/pivampicillin and amoxycillin/clavulanate in the therapy of urinary tract infection in a general practice population.
Topics: Adult; Aged; Amdinocillin; Amdinocillin Pivoxil; Amoxicillin; Ampicillin; Bacteriuria; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Escherichia coli Infections; Female; Humans; Middle Aged; Pivampicillin; Random Allocation | 1984 |
A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli Infections; Female; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Respiratory Tract Infections; Tazobactam; Ticarcillin; Urinary Tract Infections | 1998 |
Amoxycillin and clavulanic acid combination in the treatment of experimentally induced bacterial cystitis in cats.
Topics: Amoxicillin; Animals; Cat Diseases; Cats; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Cystitis; Double-Blind Method; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Male; Placebos; Urine | 1985 |
41 other study(ies) available for clavulanic acid and E coli Infections
| Article | Year |
|---|---|
Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide.
Topics: Amoxicillin; Animals; beta-Lactamase Inhibitors; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Escherichia coli Infections; Mice; Mice, Inbred ICR; Penicillanic Acid; Staphylococcal Infections; Staphylococcus aureus | 1981 |
Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Clavulanic Acid; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Nigeria; Prevalence; Young Adult | 2021 |
Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalexin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Monte Carlo Method; Probability | 2022 |
Cefixime and cefixime-clavulanate for screening and confirmation of extended-spectrum beta-lactamases in Escherichia coli.
Topics: Adolescent; Adult; Aged; beta-Lactamases; Cefixime; Cephalosporins; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2022 |
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Analysis of drug resistance genes of integrons in clinical isolates of Escherichia coli from elderly bloodstream infections.
Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefoxitin; Clavulanic Acid; Drug Resistance; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Integrons; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Escherichia coli resistance patterns, empiric and targeted antibiotic prescriptions in children: a single center experience.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Infant; Microbial Sensitivity Tests; Prescriptions; Retrospective Studies | 2022 |
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing | 2023 |
Risk factors associated with the A2C resistance pattern among E. coli isolates from broiler flocks in Canada.
Topics: Amoxicillin; Animal Husbandry; Animals; Anti-Bacterial Agents; Canada; Cefoxitin; Cephalosporins; Chickens; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Poultry Diseases; Risk Factors | 2017 |
Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Multiscale Simulations of Clavulanate Inhibition Identify the Reactive Complex in Class A β-Lactamases and Predict the Efficiency of Inhibition.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Docking Simulation; Molecular Dynamics Simulation; Thermodynamics | 2018 |
Prevalence of extended-spectrum and AmpC β-lactamase-producing Escherichia coli in Dutch dairy herds.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cattle; Cattle Diseases; Cefotaxime; Cefoxitin; Clavulanic Acid; Dairying; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Netherlands; Prevalence | 2019 |
Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Sepsis | 2013 |
CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Clavulanic Acid; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mutant Chimeric Proteins; Plasmids; Urinary Tract Infections | 2014 |
Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
Topics: Acetyltransferases; Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Cluster Analysis; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Inactivation, Metabolic; Kanamycin Kinase; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleotidyltransferases; RNA, Ribosomal, 16S; Spain; tRNA Methyltransferases | 2015 |
Urinary tract infections in adults.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acid; Cystitis; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; Incidence; Male; Middle Aged; Primary Health Care; Risk Factors; Urinary Tract Infections | 2016 |
Emergence and dominance of CTX-M-15 extended spectrum beta-lactamase among Escherichia coli isolates from children.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Cefotaxime; Ceftazidime; Child; Clavulanic Acid; Disk Diffusion Antimicrobial Tests; DNA Transposable Elements; DNA, Bacterial; DNA, Intergenic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Humans; Plasmids; Polymerase Chain Reaction; Tunisia | 2011 |
Characterization of multidrug-resistant Escherichia coli by antimicrobial resistance profiles, plasmid replicon typing, and pulsed-field gel electrophoresis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Cats; Cattle; Chloramphenicol; Clavulanic Acid; Dairy Products; DNA, Bacterial; Dogs; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genetic Association Studies; Genetic Variation; Genotype; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Replicon; Swine | 2011 |
False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cefepime; Cefpirome; Cephalosporins; Clavulanic Acid; DNA; DNA, Recombinant; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Isoelectric Focusing; Microbial Sensitivity Tests; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transformation, Bacterial | 2011 |
Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Community-Acquired Infections; DNA, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Greece; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Urinary Tract Infections | 2012 |
Combined relay therapy with oral cefixime and clavulanate for febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefixime; Child; Clavulanic Acid; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Humans; Infant; Microbial Sensitivity Tests; Urinary Tract Infections; Uropathogenic Escherichia coli | 2013 |
[Pilot study of coadjuvant treatment of recurrent cystitis in women by means of AM3 (Immnoferon)].
Topics: Adjuvants, Immunologic; Amoxicillin; Calcium Phosphates; Ciprofloxacin; Clavulanic Acid; Cystitis; Drug Evaluation; Drug Therapy, Combination; Escherichia coli Infections; Female; Follow-Up Studies; Fosfomycin; Glycopeptides; Humans; Pilot Projects; Recurrence; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vaginosis, Bacterial | 2003 |
[Meningitis caused by multiresistant E. coli after an echo-directed transrectal biopsy].
Topics: Aged; Amoxicillin; Biopsy; Brain Damage, Chronic; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Confusion; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Male; Meningitis, Bacterial; Premedication; Prostate; Rectum; Ultrasonography; Vancomycin | 2003 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections | 2004 |
Laboratory diagnosis of bloodstream infections caused by extended-spectrum beta-lactamase-producing E. coli and Klebsiella species.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cefpodoxime; Ceftizoxime; Clavulanic Acid; Drug Combinations; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Sensitivity and Specificity; Serum Bactericidal Test | 2006 |
Escherichia coli and amoxicillin/clavulanate resistance at the University Hospital of the West Indies 1994 versus 2003.
Topics: Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Time Factors; West Indies | 2007 |
[Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefotaxime; Ceftazidime; Clavulanic Acid; Cross Infection; Drug Combinations; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence; Turkey | 2007 |
Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacteroides Infections; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Klebsiella Infections; Male; Metronidazole; Mice; Oxacillin; Penicillin G; Staphylococcal Infections | 1983 |
Ribotyping differentiates relapse from reinfection in the treatment failures of Escherichia coli urinary tract infections in children.
Topics: Amoxicillin; Cefpodoxime Proxetil; Ceftizoxime; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Diagnosis, Differential; DNA, Ribosomal; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Humans; Infant; Recurrence; Treatment Failure; Urinary Tract Infections | 1994 |
Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.
Topics: Amoxicillin; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Cephalothin; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Escherichia coli Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction | 1994 |
[Bacteremia by Escherichia coli resistant to amoxycillin/clavulanic acid, ampicillin/sulbactam and piperacillin/tazobactam].
Topics: Aged; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Penicillanic Acid; Sulbactam; Tazobactam | 1994 |
Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance | 1994 |
[Tissue diffusion of amoxicillin-clavulanic acid for antibiotic prophylaxis in colorectal surgery].
Topics: Adipose Tissue; Adult; Aged; Amoxicillin; Bacteroides Infections; Clavulanic Acid; Clavulanic Acids; Colectomy; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Diffusion; Diverticulitis; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Preoperative Care; Rectum; Sigmoid Diseases; Staphylococcal Infections | 1993 |
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles | 1998 |
Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Clavulanic Acid; Drug Stability; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence | 2001 |
Non-radioactive PCR-SSCP with a single PCR step for detection of inhibitor resistant beta-lactamases in Escherichia coli.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Penicillins; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational | 2002 |
Activity of amoxycillin clavulanic/acid against Escherichia coli in vivo.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Escherichia coli Infections; Mice | 1992 |
[Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination].
Topics: Acute Disease; Aged; Aged, 80 and over; Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporinase; Cholecystitis; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Mutation | 1990 |
Pharmacokinetics and bacteriological efficacy of ticarcillin-clavulanic acid (timentin) in experimental Escherichia coli K-1 and Haemophilus influenzae type b meningitis.
Topics: Animals; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Escherichia coli Infections; Meningitis; Meningitis, Haemophilus; Microbial Sensitivity Tests; Penicillins; Rabbits; Ticarcillin | 1987 |
Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice.
Topics: Amoxicillin; Animals; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Penicillin G | 1985 |
Safety and effectiveness of ticarcillin plus clavulanic acid in the treatment of community-acquired acute pyelonephritis in adult women.
Topics: Acute Disease; Adolescent; Adult; Aged; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Evaluation; Escherichia coli Infections; Female; Humans; Middle Aged; Penicillins; Piperacillin; Pyelonephritis; Ticarcillin | 1985 |